Роль и место смесей на основе частично гидролизованных белков в питании доношенных детей: пищеварительный комфорт и предупреждение аллергии

Продолжающийся рост числа случаев развития аллергических болезней и высокая распространенность явлений пищеварительного дискомфорта у детей раннего возраста объясняют интерес педиатров, аллергологов и гастроэнтерологов к разработке и оптимизации диетологических методов профилактики и коррекции данной патологии. В статье обсуждаются современные представления о роли смесей на основе частично гидролизованных белков в питании доношенных детей для коррекции наиболее часто встречающихся функциональных расстройств пищеварения, первичной профилактики аллергии, а также их место в ступенчатой диетотерапии пищевой аллергии. Представлено описание молекулярной характеристики белков коровьего молока и свойств его аллергенов, а также описаны особенности создания и производства смесей на основе частично гидролизованных белков.

1. Szajewska H, Horvath A. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin. 2010;26(2):423–437. doi: 10.1185/03007990903510317.

2. Vandenplas Y, Alarcon P, Fleischer D, et al. Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus. J Pediatr Gastroenterol Nutr. 2016;62(1):22–35. doi: 10.1097/MPG.0000000000001014.

3. Hochwallner H, Schulmeister U, Swoboda I, et al. Cow’s milk allergy: from allergens to new forms of diagnosis, therapy and prevention. Methods. 2014;66(1):22–33. doi:10.1016/j.ymeth.2013.08.005.

4. Rueter K, Prescott SL, Palmer DJ. Nutritional approaches for the primary prevention of allergic disease: An update. J Paediatr Child Health. 2015;51(10):962–969; quiz 968–969. doi: 10.1111/jpc.12951.

5. Monaci L, Tregoat V, van Hengel AJ, Anklam E. Milk allergens, their characteristics and their detection in food: A review. Eur Food Res Technol. 2006;223(2):149–179. doi: 10.1007/S00217-005-0178-8.

6. Jost R, Fritsche R, Pahud JJ. Reduction of milk protein allergenicity through processing. Bibl Nutr Dieta. 1991;(48):127–137. doi: 10.1159/000420043.

7. Vandenplas Y, Latiff AHA, Fleischer DM, et al. Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensus. Nutrition. 2019;57:268–274. doi: 10.1016/j.nut.2018.05.018.

8. Bernard H, Creminon C, Yvon M, et al. Specificity of the human IgE response to the different purified caseins in allergy to cow’s milk proteins. Int Arch Allergy Immunol. 1998;115(3):235–244. doi: 10.1159/000023906.

9. Ruiter B, Tregoat V, M’rabet L, et al. Characterization of T cell epitopes in alphas1-casein in cow’s milk allergic, atopic and non-atopic children. Clin Exp Allergy. 2006;36(3):303–310. doi: 10.1111/j.1365-2222.2006.02436.x.

10. Spuergin P, Mueller H, Walter M, et al. Allergenic epitopes of bovine a S1-casein recognized by human IgE and IgG. Allergy. 1996; 51(5):306–312. doi: 10.1111/j.1398-9995.1996.tb04614.x.

11. Restani P, Gaiaschi A, Plebani A, et al. Cross-reactivity between milk proteins from different animal species. Clin Exp Allergy. 1999; 29(7):997–1004. doi: 10.1046/j.1365-2222.1999.00563.x.

12. Rozenfeld P, Docena GH, Anon MC, Fossati CA. Detection and identification of a soy protein component that cross-reacts with caseins from cow’s milk. Clin Exp Immunol. 2002;130(1):49–58. doi: 10.1046/j.1365-2249.2002.t01-1-01935.x.

13. Han GD, Matsuno M, Ito S, et al. Meat allergy: investigation of potential allergenic proteins in beef. Biosci Biotechnol Biochem. 2000;64(9):1887–1895. doi: 10.1271/bbb.64.1887.

14. Vicente-Serrano J, Caballero ML, Rodriguez-Perez R, et al. Sensitization to serum albumins in children allergic to cow’s milk and epithelia. Pediatr Allergy Immunol. 2007;18(6):503–507. doi: 10.1111/j.1399-3038.2007.00548.x.

15. Anderson PJ, Brooks CL, Berliner LJ. Functional identification of calcium binding residues in bovine alpha-lactalbumin. Biochemistry. 1997;36(39):11648–11654. doi: 10.1021/bi9709598.

16. Svensson M, Hakansson A, Mossberg AK, et al. Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Sci U S A. 2000;97(8):4221–4226. doi: 10.1073/pnas.97.8.4221.

17. Permyakov EA, Berliner LJ. Alpha-Lactalbumin: structure and function. FEBS Lett. 2000;473(3):269–274. doi: 10.1016/s0014-5793(00)01546-5.

18. Maynard F, Jost R, Wal JM. Human IgE binding capacity of tryptic peptides from bovine alpha-lactalbumin. Int Arch Allergy Immunol. 1997;113(4):478–488. doi: 10.1159/000237625.

19. Suutari TJ, Valkonen KH, Karttunen TJ, et al. IgE cross reactivity between reindeer and bovine milk beta-lactoglobulins in cow’s milk allergic patients. J Investig Allergol Clin Immunol. 2006; 16(5):296–302.

20. Aymard P, Durand D, Nicolai T. The effect of temperature and ionic strength on the dimerisation of beta-lactoglobulin. Int J Biol Macromol. 1996;19(3):213–221. doi: 10.1016/0141-8130(96)01130-0.

21. Adler-Nissen J. Determination of degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem. 1979;27(6):1256–1279. doi: 10.1021/jf60226a042.

22. El-Agamy EI. The challenge of cow milk protein allergy. Small Rumin Res. 2007;68(1–2):64–72. doi: 10.1016/j.smallrumres.2006.09.016.

23. Schmidt DG, Meijer RJ, Slangen CJ, van Beresteijn EC. Raising the pH of the pepsin-catalysed hydrolysis of bovine whey proteins increases the antigenicity of the hydrolysates. Clin Exp Allergy. 1995; 25(10):1007–1017. doi: 10.1111/j.1365-2222.1995.tb00404.x.

24. Ehn B-M, Ekstrand B, Bengtsson U, Ahlstedt S. Modification of IgE-binding during heat processing of the cow’s milk allergen betalactoglobulin. J Agric Food Chem. 2004;52(5):1398–1403. doi: 10.1021/jf0304371.

25. Fritsche R. The role of immune tolerance in allergy prevention. Nestle Nutr Workshop Ser Pediatr Program. 2005;56:1–9; discussion 9–14. doi: 10.1159/000086231.

26. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the essential composition of infant and follow-on formulae. EFSA J. 2014;12(7):3760. doi: 10.2903/J.EFSA.2014.3760.

27. Salvatore S, Vandenplas Y. Hydrolyzed Proteins in Allergy. In: Bhatia J, Shamir R, Vandenplas Y, eds. Protein in Neonatal and Infant Nutrition: Recent Updates. Nestle Nutr Inst Workshop Ser. 2016; 86:11–27. doi: 10.1159/000442699.

28. Greer FR, Sicherer SH, Burks AW, et al. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008;121(1):183–191. doi: 10.1542/peds.2007-3022.

29. Vandenplas Y, Bathia J, Shamir R, et al. Hydrolyzed formulas for allergy prevention. J Pediatr Gastroenterol Nutr. 2014;58(5): 549–552. doi: 10.1097/MPG.0000000000000318.

30. Tsabouri S, Douros K, Priftis KN. Cow’s milk allergenicity. Endocr Metab Immune Disord Drug Targets. 2014;14(1):16–26. doi: 10.2174/1871530314666140121144224.

31. Terracciano L, Isoardi P, Arrigoni S, et al. Use of hydrolysates in the treatment of cow’s milk allergy. Ann Allergy Asthma Immunol. 2002;89(6 Suppl 1):86–90. doi: 10.1016/s1081-1206(10)62130-8.

32. Pecquet S, Bovetto L, Maynard F, Fritsche R. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice. J Allergy Clin Immunol. 2000;105(3):514–521. doi: 10.1067/mai.2000.103049.

33. Lozano-Ojalvo D, Berin C, Tordesillas L. Immune basis of allergic reactions to food. J Investig Allergol Clin Immunol. 2019;29(1): 1–14. doi: 10.18176/jiaci.0355.

34. Kumfer AM, Commins SP. Primary prevention of food allergy. Curr Allergy Asthma Rep. 2019;19(1):7. doi: 10.1007/s11882-019-0838-6.

35. Nowak-Wegrzyn A, Chatchatee P. Mechanisms of tolerance induction. Ann Nutr Metab. 2017;70(Suppl 2):7–24. doi: 10.1159/000457915.

36. Rezende RM, Weiner HL. History and mechanisms of oral tolerance. Semin Immunol. 2017;30:3–11. doi: 10.1016/j.smim.2017.07.004.

37. Смолкин Ю.С., Грищенко Е.А. Современные представления о формировании оральной толерантности (Часть 1) // Аллергология и иммунология в педиатрии. — 2015. — Т. 43. — № 4. — С. 29–35.

38. Berin MC, Sampson HA. Mucosal immunology of food allergy. Curr Biol. 2013;23(9):R389–R400. doi: 10.1016/j.cub.2013.02.043.

39. Tanoue T, Atarashi K, Honda K. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 2016;16(5): 295–309. doi: 10.1038/nri.2016.36.

40. Hadis U, Wahl B, Schulz O, et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity. 2011;34(2):237–246. doi: 10.1016/j.immuni.2011.01.016.

41. Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology. 2007;132(5):1705–1717. doi: 10.1053/j.gastro.2007.02.044.

42. Jaensson E, Uronen-Hansson H, Pabst O, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med. 2008; 205(9):2139–2149. doi: 10.1084/jem.20080414.

43. Klebanoff CA, Spencer SP, Torabi-Parizi P, et al. Retinoic acid controls the homeostasis of precDC-derived splenic and intestinal dendritic cells. J Exp Med. 2013;210(10):1961–1976. doi: 10.1084/jem.20122508.

44. Tsuji NM, Kosaka A. Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol. 2008;29(11): 532–540. doi: 10.1016/j.it.2008.09.002.

45. Украинцев С.Е. Профилактика аллергии: от иммунологии беременности до вскармливания детей первых месяцев жизни // Вопросы современной педиатрии. — 2016. — Т. 15. — № 6. — С. 604–609. doi.org/10.15690/vsp.v15i6.1658.

46. Wang Y, Allen KJ, Koplin JJ. Dietary intervention for preventing food allergy in children. Curr Opin Pediatr. 2017;29(6):704–710. doi: 10.1097/MOP.0000000000000552.

47. Grulee C, Sanford H. The influence of breast and artificial feeding on infantile eczema. J Pediatr. 1936;9(2):223–225. doi: 10.1016/S0022-3476(36)80058-4.

48. Lucas A, Brooke O, Morley R, et al. Early diet of preterm infants and development of allergic or atopic disease: randomized prospective study. BMJ. 1990;300(6728):837–840. doi: 10.1136/bmj.300.6728.837.

49. Gdalevich M, Mimouni D, David M. Breastfeeding and the onset of atopic dermatitis in childhood: a systematic review and metaanalysis of prospective studies. J Am Acad Dermatol. 2001;45(4): 520–527. doi: 10.1067/mjd.2001.114741.

50. Von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol. 2007;119(3): 18–25. doi: 10.1016/j.jaci.2006.11.017.

51. Von Berg A, Filipiak-Pittroff B, Kramer U, et al. Allergies in highrisk schoolchildren after early intervention with cow’s milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study. J Allergy Clin Immunol. 2013;131(6): 1565–1573. doi: 10.1016/j.jaci.2013.01.006.

52. Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev. 2006;18(4):CD003664. doi: 10.1002/14651858.CD003664.pub3.

53. Szajewska H, Horvath A. A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated metaanalysis. World Allergy Organ J. 2017;26;10(1):27. doi: 10.1186/s40413-017-0158-z.

54. Von Berg A, Filipiak-Pittroff B, Schulz H, et al. Allergic manifestation 15 years after early intervention with hydrolyzed formulas — the GINI Study. Allergy. 2016;71(2):210–219. doi: 10.1111/all.12790.

55. Spieldenner J, Belli D, Dupont C, et al. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses. Ann Nutr Metab. 2011;59(Suppl 1):44–52. doi: 10.1159/000334232.

56. Botteman MF, Bhanegaonkar AJ, Horodniceanu EG, et al. Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore. Singapore Med J. 2018;59(8):439–448. doi: 10.11622/smedj.2017113.

57. Намазова–Баранова Л.С., Макарова С.Г., Новик Г.А., Вишнева Е.А. Национальные клинические рекомендации по оказанию медицинской помощи детям с аллергией к белкам коровьего молока. Краткий обзор документа // Российский аллергологический журнал. — 2017. — Т. 14. — № 2. — С. 55–65.

58. Первичная профилактика аллергии у детей. Согласительный документ Ассоциации детских аллергологов и иммунологов России. — М.; 2010.

59. Wood RA, Sicherer SH, Vickery BP, et al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013; 131(3):805–812. doi: 10.1016/j.jaci.2012.10.060.

60. Elizur A, Rajuan N, Goldberg MR, et al. Natural course and risk factors for persistence of IgE-mediated cow’s milk allergy. J Pediatr. 2012;161(3):482–487.e1. doi: 10.1016/j.jpeds.2012.02.028.

61. Sackesen C, Altintas DU, Bingol A, et al. Current Trends in Tolerance Induction in Cow’s Milk Allergy: From Passive to Proactive Strategies. Front Pediatr. 2019;7:372. doi: 10.3389/fped.2019.00372.

62. Fiocchi A, Brozek J, Schunemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol. 2010; 21(Suppl 21):1–125. doi: 10.1111/j.1399-3038.2010.01068.x.

63. Vandenplas Y. Prevention and Management of Cow’s Milk Allergy in Non-Exclusively Breastfed Infants. Nutrients. 2017;9(7):731. doi: 10.3390/nu9070731.

64. Luyt D, Ball H, Makwana N, et al. BSACI guideline for the diagnosis and management of cow’s milk allergy. Clin Exp Allergy. 2014;44(5):642–672. doi: 10.1111/cea.12302.

65. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow’s milk allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2012;42(3):363–374. doi: 10.1111/j.1365-2222.2011.03948.x.

66. D’Auria E, Salvatore S, Pozzi E, et al. Cow’s Milk Allergy: Immunomodulation by Dietary Intervention. Nutrients. 2019;11(6): 1399. doi: 10.3390/nu11061399.

67. Berni Canani R, Nocerino R, Terrin G, et al. Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013;163(3):771–777. doi: 10.1016/j.jpeds.2013.03.008.

68. Kim AR, Kim HS, Nam ST, et al. Mesenteric IL-10-producing CD5+ regulatory B cells suppress cow’s milk casein-induced allergic responses in mice. Sci Rep. 2016;6:19685. doi: 10.1038/srep19685.

69. Kiewiet MBG, Dekkers R, Gros M, et al. Toll-like receptor mediated activation is possibly involved in immunoregulating properties of cow’s milk hydrolysates. PLoS One. 2017;12(6): e0178191. doi: 10.1371/journal.pone.0178191.

70. Inuo C, Tanaka K, Suzuki S, et al. Oral Immunotherapy Using Partially Hydrolyzed Formula for Cow’s Milk Protein Allergy: A Randomized, Controlled Trial. Int Arch Allergy Immunol. 2018; 177(3):259–268. doi: 10.1159/000490804.

71. Inuo C, Tanaka K, Nakajima Y, et al. Tolerability of partially and extensively hydrolysed milk formulas in children with cow’s milk allergy. Asia Pac J Clin Nutr. 2019;28(1):49–56. doi: 10.6133/apjcn.201903_28(1).0008.

72. Astier C, Morisset M, Roitel O, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118:250–256. doi: 10.1016/j.jaci.2006.04.053.

73. Vandenplas Y, Al-Hussaini B, Al-Mannaei K, et al. Prevention of Allergic Sensitization and Treatment of Cow’s Milk Protein Allergy in Early Life: The Middle-East Step-Down Consensus. Nutrients. 2019;11(7).1444. doi: 10.3390/nu11071444.

74. Vandenplas Y, Benninga M, Broekaert I, et al. Functional gastrointestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies [published correction appears in Acta Paediatr. 2016;105(8):984]. Acta Paediatr. 2016; 105(3):244–252. doi:10.1111/apa.13270.

75. Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recom mendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516–554. doi: 10.1097/MPG.0000000000001889.

76. Vandenplas Y, Hauser B, Salvatore S. Functional Gastrointestinal Disorders in Infancy: Impact on the Health of the Infant and Family. Pediatr Gastroenterol Hepatol Nutr. 2019;22(3):207–216. doi: 10.5223/pghn.2019.22.3.207.

77. Salvatore S, Abkari A, Cai W, et al. Review shows that parental reassurance and nutritional advice help to optimise the management of functional gastrointestinal disorders in infants. Acta Paediatr. 2018;107(9):1512–1520. doi: 10.1111/apa.14378.

78. Salvatore S, Savino F, Singendonk M, et al. Thickened infant formula: What to know. Nutrition. 2018; 49:51–56. doi: 10.1016/j.nut.2017.10.010.

79. Vandenplas Y, Leluyer B, Cazaubiel M, et al. Double-blind comparative trial with two antiregurgitation formulae. J Pediatr Gastroenterol Nutr. 2013;57(3):389–393. doi: 10.1097/MPG.0b013e318299993e.

80. Indrio F, Riezzo G, Giordano P, et al. Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility. Nutrients. 2017;9(11):1181. doi: 10.3390/nu9111181.

81. Gonzalez-Bermudez CA, Frontela-Saseta C, Lopez-Nicolas R, et al. Effect of adding different thickening agents on the viscosity properties and in vitro mineral availability of infant formula. Food Chem. 2014;159:5–11. doi: 10.1016/j.foodchem.2014.02.168.

82. Horvath A, Dziechciarz P, Szajewska H. The effect of thickened feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics. 2008;122(6):e1268–1277. doi: 10.1542/peds.2008-1900.

83. Макарова Е.Г., Клепикова Т.В., Украинцев С.Е. Минимальные расстройства пищеварения: когда проблемы есть, а лечить еще рано // Вопросы современной педиатрии. — 2019. — Т. 18. — № 4. — С. 247–256. doi: 10.15690/vsp.v18i4.2041.

84. Gutierrez-Castrellon P, Indrio F, Bolio-Galvis A, et al. Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis. Medicine (Baltimore). 2017; 96(51):e9375. doi: 10.1097/MD.0000000000009375.

85. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment metaanalysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2): 163–171. doi: 10.1016/j.jclinepi.2010.03.016.

86. Красавина Н.А., Кабанова Н.К., Перминова О.А. и др. Возможности диетологической коррекции сочетанных форм функциональных расстройств пищеварения у детей первого года жизни: результаты клинической апробации нового продукта в открытом сравнительном проспективном исследовании // Вопросы детской диетологии. — 2017. — Т. 15. — № 6. — С. 18–24. doi: 10.20953/1727-5784-2017-6-18-24.

87. Tabbers MM, Di Lorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):265–281. doi: 10.1097/MPG.0000000000000266.

88. Czerkies LA, Kineman BD, Cohen SS, et al. A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially Hydrolyzed Whey or Intact Protein-Based Infant Formulas. Int J Pediatr. 2018; 2018:4969576. doi: 10.1155/2018/4969576.

89. Vandenplas Y, Munasir Z, Hegar B, et al. A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants. Korean J Pediatr. 2019;62(5):149–154. doi: 10.3345/kjp.2018.07276.